High-throughput sequencing identified MIR-193a as a potential biomarker of non-alcoholic fatty liver disease activity
2012 ◽
Vol 42
(3)
◽
pp. 273-279
◽
2021 ◽
Vol 83
(1)
◽
pp. 957-963
2010 ◽
Vol 64
(4)
◽
pp. 275-281
◽